NSE
Sun Pharmaceutical Industries
SUNPHARMA.NS
₹1,920.00
+6.70 +0.35%As of 28 Aug 2026, 16:07 IST
Up period
Down period
10-period average
30-period average
NIFTY 50, rebased
Strength vs NIFTY 50
Log scale
5Y range: ₹737.15 – ₹2,001.10, +143.90% over the period.
Key statistics
- Previous close
- ₹1,913.30
- Open
- ₹1,925.00
- Day high
- ₹1,931.00
- Day low
- ₹1,903.80
- 52w high
- ₹2,046.90
- 52w low
- ₹1,548.00
- Volume
- 11.41 L
- Currency
- INR
Technicals
- 50d average
- ₹1,922.70 -0.14%
- 200d average
- ₹1,797.20 +6.83%
- From 52w high
- -6.20%
- From 52w low
- +24.03%
- Volume vs 50d
- 0.55× avg 20.77 L
Relative to NIFTY 50
| Period | SUNPHARMA | NIFTY 50 | Excess |
|---|---|---|---|
| 3M | +6.87% | +3.39% | +3.48% |
| 6M | +10.84% | -5.98% | +16.81% |
| 1Y | +22.82% | -1.03% | +23.85% |
Watchlist
Sign in or create an account to track this symbol.
JSON
GET /api/quote/SUNPHARMA.NS
GET /api/history/SUNPHARMA.NS?range=5Y
CANSLIM
0 of 1 testable criterion
5 of the six company criteria could not be evaluated from what this server holds. Those are marked ? below and count towards neither side — an absent figure is not a failed test.
- Current quarterly earnings
- Only 1 filed quarter(s) — a year-on-year comparison needs five.
- Annual earnings growth
- Needs two full trailing years — the archive has 1 filed quarter(s).
- New price high
- 6.2% below its 52 week high.
- Supply and demand
- No volume history for this symbol.
- Leader, not laggard
- No relative strength rating yet — run `php artisan market:strength --rank`.
- Institutional sponsorship
- No shareholding data — run `php artisan market:ownership --sync`.
C
?
A
?
N
✕
S
?
L
?
I
?
M
✕
Market direction — the market, not this stock
Market in correction. The index is below both its fifty and two-hundred day averages.
- Thresholds are O'Neil's own — 25% quarterly and annual earnings growth, a relative strength rating of 80, 17% return on equity. They come from his study of past US market winners and are conventions rather than laws.
- I reads the current level of institutional holding. What CANSLIM actually asks for is a rising number of institutional holders, which needs several quarters of history this app has only just started recording.
- M is identical for every company on the site, so it is reported rather than counted — six letters describe this company and one describes the market. The CANSLIM screen shows the full reading.
Fundamentals
- Market cap
- ₹460,666 Cr
- P/E (TTM)
- —
- P/B
- —
- P/S
- —
- EPS (TTM)
- —
- Book value / share
- —
- ROE
- —
- ROA
- —
- Debt / equity
- —
- Net margin
- —
- Operating margin
- —
- Revenue (TTM)
- —
- Face value
- 1.00
- Shares
- 239.93 Cr
- ISIN
- INE044A01036
- BSE code
- 524715
- Partial history Only 1 quarter filed so far, so anything trailing-twelve-month — P/E, EPS, ROE, margins — is left blank rather than estimated from less than a year.
- Shares 239.93 crore shares, from paid-up capital ÷ face value
- Ttm only 1 quarter(s) filed — no trailing year yet
- Source Consolidated filings with NSE, priced at ₹1,920.00. No third party — every figure is derived from documents this server holds.
Reported results
1 quarters, as filed| Quarter | Revenue | YoY | PBT | Net profit | YoY | Margin | EPS |
|---|---|---|---|---|---|---|---|
| Jun '26 | ₹15,300 Cr | — | ₹4,099 Cr | ₹2,901 Cr | — | 19.0% | 12.10 |
Consolidated, as filed with NSE. Latest document disseminated 31 Jul 2026, 18:24.